Author

Jorge Carrillo

Instituto de Salud Carlos IIIORCID 0000-0003-0221-5948Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Benjamin TrinitéiD· 3 shared Julià BlancoiD· 3 shared Anna Pons-GrífolsiD· 2 shared Bonaventura ClotetiD· 2 shared Ferran Tarrés-FreixasiD· 2 shared Víctor UrreaiD· 2 shared Alba González-AumatelliD· 1 shared Alfonso ValenciaiD· 1 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Benjamin TrinitéORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologyJCI InsightPeer-reviewedFeb 19, 2026

Pediatric Long COVID Is Characterized by Myeloid CCR6 Suppression and Immune Dysregulation

Jon Izquierdo-Pujol, Núria Pedreño-López, Tetyana Pidkova…·Sara Morón‐López

This study identifies immune dysregulation and myeloid CCR6 suppression in pediatric long COVID, with CCR6 expression distinguishing long COVID from controls.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky

MicrobiologymBioPeer-reviewedApr 24, 2025

A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model.

Anna Pons-Grífols, Ferran Tarrés-Freixas, Mónica Pérez…·Julià Blanco

This paper introduces a knock-in mouse model for SARS-CoV-2 infection that replicates respiratory issues but avoids neurological disease seen in the K18-hACE2 model.

11 citationstop 2%

mouseexperimental assay

𝕏 PostBluesky

ImmunologybioRxivPreprintSep 7, 2023

VLP-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in mice

Ana Barajas, Pep Amengual-Rigo, Anna Pons-Grífols…·Julià Blanco

This study develops a neoantigen selection pipeline and a VLP-based vaccine platform to enhance immunogenicity and antitumor activity in mice.

DOI 10.1101/2023.09.07.556652

mouseproteomics

𝕏 PostBluesky